TacticScaleWhat Corteva Does & How It Makes Money (CTVA)
Updated October 2026 · reflects Corteva's latest reported financials
Agriculture company selling crop seeds and crop protection chemicals. Corteva earns money by selling seeds with its own genetics and traits, plus crop protection chemicals, to farmers and the agricultural input industry.
How Corteva makes money
Corteva earns money by selling seeds with its own genetics and traits, plus crop protection chemicals, to farmers and the agricultural input industry. It sells across North America, Latin America, Asia Pacific, Europe, the Middle East, and Africa.
What Corteva does
Corteva, Inc. is an agriculture company headquartered in Indianapolis, Indiana, with roots going back to 1802. It has two segments. The Seed segment develops germplasm and trait technologies that help crops resist weather, disease, insects, and herbicides, and that add food and nutrition characteristics. It also offers digital tools that help farmers choose products and maximize yield and profitability. The Crop Protection segment sells herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. These protect crops from weeds, pests, and disease and support crop health above and below ground, including through seed-applied technologies. Corteva operates in the United States, Canada, Latin America, Asia Pacific, Europe, the Middle East, and Africa.
Products & services
- Seed germplasm and trait technologies
- Herbicides
- Insecticides
- Nitrogen stabilizers
- Pasture and range management herbicides
- Digital farm decision tools
What is Corteva worth?
On an owner-earnings DCF, Corteva's most-likely value is about $66 versus a recent price near $13 (396% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$36) with a margin of safety — so the honest verdict here is “Deeply discounted.” Fair value earns its keep only at the extremes, not in the wide middle.
On the financials alone, $13 is below even the no-growth floor ($36); the market's discount — expectations and sentiment beyond the numbers — is pricing in ≈ -21.0%/yr. A bargain only if that pessimism is overdone.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
FMC (FMC) · CAC Nantong Chemical (301665.SZ) · Yuan Long Ping High-Tech Agriculture (000998.SZ) · Jiangsu Provincial Agricultural Reclamation and Development (601952.SS) · CF Industries (CF)